Cost savings and safety of ICD remote control by telephone: A prospective, observational study

Journal of Telemedicine and Telecare

Volumn 16, Issue 7, 2010, Pages 403-408

  Bikou, Olympia ^a   Licka, Manuela ^a   Kathoefer, Sven ^a   Katus, Hugo A ^a   Bauer, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COST BENEFIT ANALYSIS; DEFIBRILLATOR; ECONOMICS; FEMALE; HEALTH CARE COST; HOME CARE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TELEMETRY; TELEPHONE;

AGED; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH CARE COSTS; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TELEMETRY; TELEPHONE;

EID: 78149246712     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1258/jtt.2010.090810     Document Type: Article

References (31)

1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a efibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37
4. Lercher P, Rotman B, Scherr D, Kraxner W, Luha O, Klein W. The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital - do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter- defibrillator? Wien Klin Wochenschr 2003;115:167-74 [German]
5. Higgins SL. Impact of the Multicenter Automatic Defibrillator Implantation Trial on implantable cardioverter defibrillator indication trends. Am J Cardiol 1999;83:79D-82D
6. Biotronik. See http://www.biotronik.com (last checked 2 February 2010)
7. Medtronic CareLink Network. See http://www.medtronic.com/carelink (last checked 2 February 2010)
8. St Jude Medical. See http://www.sjm.com (last checked 2 February 2010)
9. Boston Scientific. See http://www.bostonscientific.com (last checked 21 July 2010)
10. Wallbruck K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E. The value of permanent follow-up of implantable pacemakers - first results of a European trial. Biomed Tech (Berl) 2002;47 (Suppl. 1) Pt 2:950-3
11. Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: future perspectives. Europace 2003;5:139-42
12. Chun S. Improved patient care in the US with home monitoring pacemakers. Europace 2002;3 (Suppl. A):A71
13. Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004;11:161-6
14. Dougherty CM, Thompson EA, Lewis FM. Long-term outcomes of a telephone intervention after an ICD. Pacing Clin Electrophysiol 2005;28:1157-67
15. Compton S, Balaban K, Wilkoff BL, et al. Initial experience of the remote ICD monitoring system-housecall plus. Europace 2005;7:86
16. Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace 2009;11:701-9
17. Jung W, Rillig A, Birkemeyer R, Miljak T, Meyerfeldt U. Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. J Interv Card Electrophysiol 2008;23:73-85
18. Fauchier L, Sadoul N, Kouakam C, et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2005;28 (Suppl. 1):S255-9
19. Elsner CH, Sommer P, Piorkowski C, et al. A prospective multicenter comparison trial of home monitoring against regular follow-up in MADIT II patients: additional visits and cost impact. Comput Cardiol 2006;33:241-4
20. Deharo JC, Djiane P. Home monitoring: what can we expect in the future? Clin Res Cardiol 2006;95 (Suppl. 3):36-9
21. Raatikainen MJ, Uusimaa P, van Ginneken MM, Janssen JP, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace 2008;10:1145-51
22. [anonymous]. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83
23. Heidbuchel H, Lioen P, Foulon S, et al. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 2008;10:351-7
24. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol 2006;95 (Suppl. 3):3-9
25. Senges-Becker JC, Klostermann M, Becker R, et al. What is the "optimal" follow-up schedule for ICD patients? Europace 2005;7:319-26
26. Kron J, Herre J, Renfroe EG, et al. Lead-and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:92-8
27. Gross J, Zilo P, Ferrick K, Fisher JD, Furman S. Sudden death mortality in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 1991;14:250-4
28. Toselli T, Regoli F, Pratola C. Implantable cardioverter-defibrillator home monitoring technology. Ital Heart J 2004;5 (Suppl.1):30-31
29. Lamaison D, Motreff P, Jean F, et al. The place of telemedicine in rhythmology and cardiac pacing. Arch Mal Coeur Vaiss 2004;97:1160-4 [French]
30. Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ. Twiddler's syndrome detected by home monitoring device. Pacing Clin Electrophysiol 2004;27:1151-2
31. Halperin D, Heydt-Benjamin TS, Ransford B, et al. Pacemakers and implantable cardiac defibrillators: software radio attacks and zero-power defenses. In: Proceedings of the IEEE Symposium on Security and Privacy 2008:129-42